AU2001277429A1 - Method to treat infectious diseases and/or to enhance antimicrobial efficacy of drugs - Google Patents

Method to treat infectious diseases and/or to enhance antimicrobial efficacy of drugs

Info

Publication number
AU2001277429A1
AU2001277429A1 AU2001277429A AU7742901A AU2001277429A1 AU 2001277429 A1 AU2001277429 A1 AU 2001277429A1 AU 2001277429 A AU2001277429 A AU 2001277429A AU 7742901 A AU7742901 A AU 7742901A AU 2001277429 A1 AU2001277429 A1 AU 2001277429A1
Authority
AU
Australia
Prior art keywords
drugs
infectious diseases
antimicrobial efficacy
treat infectious
enhance antimicrobial
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001277429A
Inventor
Pierre Borgeat
Louis Flamand
Jean Gosselin
Michel J. Tremblay
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Virocell Inc
Original Assignee
Virocell Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Virocell Inc filed Critical Virocell Inc
Publication of AU2001277429A1 publication Critical patent/AU2001277429A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2001277429A 2000-08-02 2001-07-23 Method to treat infectious diseases and/or to enhance antimicrobial efficacy of drugs Abandoned AU2001277429A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US63163700A 2000-08-02 2000-08-02
US09/631,637 2000-08-02
PCT/CA2001/001068 WO2002009677A2 (en) 2000-08-02 2001-07-23 Method to treat infectious diseases and/or to enhance antimicrobial efficacy of drugs

Publications (1)

Publication Number Publication Date
AU2001277429A1 true AU2001277429A1 (en) 2002-02-13

Family

ID=24532074

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001277429A Abandoned AU2001277429A1 (en) 2000-08-02 2001-07-23 Method to treat infectious diseases and/or to enhance antimicrobial efficacy of drugs

Country Status (5)

Country Link
US (1) US20040131701A1 (en)
EP (1) EP1343507A2 (en)
AU (1) AU2001277429A1 (en)
CA (1) CA2417627A1 (en)
WO (1) WO2002009677A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1674081A1 (en) 2004-12-23 2006-06-28 KTB Tumorforschungsgesellschaft mbH Preparation of lipid based nano-particles with a dual asymetric centrifuge
RU2609865C1 (en) * 2015-09-29 2017-02-06 Государственное бюджетное образовательное учреждение высшего профессионального образования "Алтайский государственный медицинский университет" Министерства здравоохранения Российской Федерации Method of treating children with acute respiratory infections accompanied with secondary immune deficiency

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5871779A (en) * 1994-01-18 1999-02-16 Mount Sinai Hospital Corporation Treatment of arthropathies with vanadate compounds or analogues thereof
US5565491A (en) * 1994-01-31 1996-10-15 Bristol-Myers Squibb Company Use of phosphotyrosine phospatase inhibitors for controlling cellular proliferation
CA2280249A1 (en) * 1999-08-12 2001-02-12 Universite Laval Vanadium compounds as anti-angiogenics and as inhibitors of endothelin production
CA2389348A1 (en) * 1999-10-26 2001-05-03 Virocell Inc. Use of a bis-peroxovanadium compound for the treatment of immunosuppressed patients

Also Published As

Publication number Publication date
US20040131701A1 (en) 2004-07-08
WO2002009677A3 (en) 2003-07-17
EP1343507A2 (en) 2003-09-17
CA2417627A1 (en) 2002-02-07
WO2002009677A2 (en) 2002-02-07

Similar Documents

Publication Publication Date Title
HUP0301121A3 (en) Topical pharmaceutical formulations and methods of treatment
AU2002324914A1 (en) Pharmaceutical compositions of drug-oligomer conjugates and methods of treating diseases therewith
IL162533A0 (en) Chalcone derivatives and their use to treat diseases
AU2001280702A1 (en) Compounds and methods for treatment and diagnosis of chlamydial infection
GB0020351D0 (en) Treatment of hyperproliferative diseases
AUPQ877300A0 (en) Topical treatment of skin
AU2002952597A0 (en) Topical parasiticide formulations and methods of treatment
AUPQ622600A0 (en) Treatment and/or prevention of ocular pain
AU6887101A (en) Copolymers and methods of treating prion-related diseases
AUPQ344799A0 (en) Treatment of respiratory diseases and infections
AU2002220257A1 (en) Methods of treatment involving human mda-7
AU2001287534A1 (en) Use of flupirtine to treat tinnitus
AU2001277429A1 (en) Method to treat infectious diseases and/or to enhance antimicrobial efficacy of drugs
AU2001267165A1 (en) Prevention and treatment of mycoplasma-associated diseases
AU2003213898A1 (en) Prevention and treatment of mycoplasma-associated diseases
AU2001258575A1 (en) Treatment of cancer and neurological diseases
AU2002365281A1 (en) Thiochromenones used to combat painful conditions and neurodegenerative diseases
IL155819A0 (en) Methods of treatment comprising administration of substance p
AU2002222125A1 (en) Prevention and treatment of tachyphylactic response
AU2001262741A1 (en) Medicines for the prevention and treatment of neurodegenerative diseases
AU2002360523A1 (en) Compounds to treat hiv infection and aids
AU2001281465A1 (en) Treatment of rosacea
AU2001267177A1 (en) Diagnosis and treatment of herpes infections
AU5812601A (en) Treatment of il-10 deficiencies
AU2001236806A1 (en) Targeted destruction of pests